New bonding modes for boraamidinate ligands in heavy group 15 complexes: fluxional behavior of the 1:2 complexes, LiM[PhB(NtBu)2]2 (M = As, Sb, Bi)

The reactions of MCl3 with Li2[PhB(NtBu)2] in 1:1, 1:1.5, and 1:2 molar ratios in diethyl ether produced the monoboraamidinates ClM[PhB(NtBu)2] (1a, M = As; 1b, M = Sb; 1c, M = Bi), the novel 2:3 boraamidinate complexes [PhB(NtBu)2]M-micro-N(tBu)B(Ph)N(tBu)M[PhB(NtBu)2] (2b, M = Sb; 2c, M = Bi), and the bisboraamidinates LiM[PhB(NtBu)2]2 (3a, 3a.OEt2, M = As; 3b, M = Sb; 3c.OEt2, M = Bi), respectively. The 2:3 complexes 2b and 2c were also observed in the reactions carried out in a 1:2 molar ratio at room temperature. All complexes have been characterized by multinuclear NMR spectroscopy (1H, 7Li, 11B, and 13C) and by single-crystal X-ray structural determinations. The molecular units of the mono-boraamidinates 1a-c are isostructural, but their crystal packing is distinct as a result of stronger intermolecular close contacts going from 1a to 1c. In the novel 2:3 bam complexes 2b and 2c, each metal center is N,N'-chelated by a bam ligand and these two [M(bam)]+ units are bridged by the third [bam]2- ligand. The structures of the unsolvated bis-boraaminidate complexes 3a and 3b consist of [Li(bam)]- and [M(bam)]+ monomeric units linked by Li-N and M-N bonds to give a tricyclic structure. Solvation of the Li+ ion by diethyl ether results in a bicyclic structure composed of four-membered BN2As and six-membered BN3AsLi rings in 3a.OEt2. In contrast, the analogous bismuth complex 3c.OEt2 exhibits a tetracyclic structure. Variable-temperature NMR studies reveal that the nature of the fluxional behavior of 3a-c in solution is dependent on the group 15 center.     

Thioether-functionalized ferrocenyl-bis(phosphonite), Fe{(C5H4)P(-OC10H6(micro-S)C10H6O-)}2: synthesis, coordination behavior, and application in Suzuki-Miyaura cross-coupling reactions

The thioether-functionalized metalloligand ferrocenyl-bis(phosphonite), Fe(C5H4PR)2 (4, R=-OC10H6(micro-S)C10H6O-) is synthesized in three steps starting from ferrocene, and its coordination behavior toward various transition-metal derivatives is described. The reactions of 4 with [Rh(CO)2Cl]2 or M(COD)Cl2 afforded the chelate complexes, cis-[Rh(CO)Cl{Fe(C5H4PR)2-kappaP,kappaP}] (5) or cis-[MCl2{Fe(C5H4PR)2-kappaP,kappaP}] (6, M=PdII; 7, M=PtII), respectively. However, treatment of 4 with CuX (X=Cl, Br, and I) produces binuclear complexes, [Cu2(micro-X)2(MeCN){Fe(C5H4PR)2-kappaP,kappaP}] (8, X=Cl; 9, X=Br; 10, X=I) where the sulfur atom on one side of the ligand is involved in a weak interaction with the copper center. Reaction of 4 with 1 equiv of Ag(PPh3)OTf gives the mononuclear chelate complex [Ag(OTf)PPh3{Fe(C5H4PR)2-kappaP,kappaP}] (11), whereas treatment with 2 equiv of AuCl(SMe2) produces the dinuclear gold complex [Au(Cl){Fe(C5H4PR)2-kappaP,kappaP}Au(Cl)] (12). The crystal structures of 10 and 12 are reported, where a strong metallophilic interaction is observed between the closed-shell metal centers. The palladium complex 6 catalyzes the Suzuki cross-coupling reactions of aryl bromides with phenylboronic acid with excellent turnover numbers (TON up to 1.36x10(5)).     

Synthesis and structural studies of Rh, Pd, Ni complexes and one-pot synthesis of binuclear Ru complex [(η-p-cymene)Ru(μ2-Cl)3Ru{PhN(P(OC6H4OMe-o)2)2}Cl]

The Rh^I, Ru^II, Pd^I and Ni^II complexes of the aminobis(phosphonite), PhN(P(OC₆H₄OMe-o)₂)₂ (1) are reported. The reactions of 1 with [Rh(COD)Cl]₂ in 1:1 and 2:1 molar ratio afford the mono- and diolefin substituted chloro bridged chelate complexes, [(COD)Rh₂(μ₂-Cl)₂{PhN(P(OC₆H₄OMe-o)₂)₂}] (2) and [Rh(μ₂-Cl){PhN(P(OC₆H₄OMe-o)₂)₂}]₂ (3), respectively. Similarly, the cationic mono- and bis-chelate complexes, [Rh(COD){PhN(P(OC₆H₄OMe-o)₂)₂}]OTf (4) and [Rh{PhN(P(OC₆H₄OMe-o)₂)₂}₂]OTf (5) are obtained by treating 1 with [Rh(COD)Cl]₂ in the presence of AgOTf in appropriate ratios. The dinuclear Rh^I carbonyl complex, [RhCl(CO){μ-PhN(P(OC₆H₄OMe-o)₂)₂}]₂ (6) is prepared by treating 1 with 0.5 equiv. of [Rh(CO)₂Cl]₂. Reaction of 1 with cis-[NiBr₂(DME)] (DME = 1,2-dimethoxyethane) affords [{PhN(P(OC₆H₄OMe-o)₂)₂}NiBr₂] (7) whereas with [Ru-(η⁶-p-cymene)Cl₂]₂ in refluxing THF medium produces an interesting and rare bimetallic Ru^II complex, [(η⁶-p-cymene)Ru(μ₂-Cl)₃Ru{PhN(P(OC₆H₄OMe-o)₂)₂}Cl] (8). Redox condensation of the Pd⁰ and Pd^II derivatives with 1 affords the dinuclear Pd^I complex, [PdBr{μ-PhN(P(OC₆H₄OMe-o)₂)₂}]₂ (9). The formation and structure of complexes 2-9 are assigned through various spectroscopic and micro analysis data. The molecular structures of 5 and 7-9 are confirmed by single crystal X-ray diffraction studies.     

Crystal and Molecular Structure of Desmodin

The crystal structure of the title compound has been determined from X‐ray diffraction. The compound crystallizes from benzene in the orthorhombic system, space group P2₁2₁2₁, with unit cell parameters: a = 8.485(2), b = 9.816(2), c = 22.597(4) Å, Z = 4, V = 1881.9(7) ų. The structure was determined by direct methods and refined to a final R‐factor of 0.04. Six membered rings B and E are planar. Ring A and ring C are in slightly distorted sofa conformation. Ring D is in envelope conformation. The structure is stabilised by weak intermolecular C‐H...O hydrogen bonds.     

Phosphine free diamino-diol based palladium catalysts and their application in Suzuki-Miyaura cross-coupling reactions

Inexpensive air and moisture stable diamino-diol ligands [(2-OH-C₁₀H₆)CH₂(μ-NC₄H₈N)CH₂(C₁₀H₆-2-OH)] (1) and [(5-^tBuC₆H₃-2-OH)CH₂(μ-NC₄H₈N)CH₂(5-^tBuC₆H₃-2-OH)] (2) were synthesized by reacting corresponding alcohols with formaldehyde and piperazine. Treatment of ligands 1 and 2 with Pd(OAc)₂ in 1:1 molar ratio afforded neutral palladium complexes [Pd{(OC₁₀H₆)CH₂(μ-NC₄H₈N)CH₂(C₁₀H₆O)}] (3) and [Pd{(5-^tBuC₆H₃-2-O)CH₂(μ-NC₄H₈N)CH₂(5-^tBuC₆H₃-2-O)}] (4) in good yield. The palladium complexes 3 and 4 are employed in Suzuki-Miyaura cross-coupling reactions between phenylboronic acid and several aryl chlorides or bromides. They are found to be competent homogeneous catalysts for a variety of substrates to afford the coupled products in good to excellent yields. The crystal structures of compounds 2 and 4 are also reported.     

Synthesis of neutral (Pd(II), Pt(II)), cationic (Pd(II)), and water-induced anionic (Pd(II)) complexes containing new mesocyclic thioether-aminophosphonite ligands and their application in the Suzuki cross-coupling reaction

Mesocyclic thioether-aminophosphonite ligands, {-OC10H6(mu-S)C10H6O-}PNC4H8O (2a, 4-(dinaphtho[2,1-d:1',2'-g][1,3,6,2]dioxathiaphosphocin-4-yl)morpholine) and {-OC10H6(mu-S)C10H6O-}PNC4H8NCH3 (2b, 1-(dinaphtho[2,1-d:1',2'-g][1,3,6,2]dioxathiaphosphocin-4-yl)-4-methylpiperazine) are obtained by reacting {-OC10H6(mu-S)C10H6O-}PCl (1) with corresponding nucleophiles. The ligands 2a and 2b react with (PhCN)2PdCl2 or M(COD)Cl2 (M = Pd(II) or Pt(II)) to afford P-coordinated cis-complexes, [{(-OC10H6(mu-S)C10H6O-)PNC4H8X-kappaP}2MCl2] (3a, M = Pd(II), X = O; 3b, M = Pd(II), X = NMe; 4a, M = Pt(II), X = O; 4b, M = Pt(II), X = NMe). Compounds 2a and 2b, upon treatment with [Pd(eta3-C3H5)Cl]2 in the presence of AgOTf, produce the P,S-chelated cationic complexes, [{(-OC10H6(mu-S)C10H6O-)PNC4H8X-kappaP,kappaS}Pd(eta3-C3H5)](CF3SO3) (5a, X = O and 5b, X = NMe). Treatment of 2a and 2b with (PhCN)2PdCl2 in the presence of trace amount of H2O affords P,S-chelated anionic complexes, [{(-OC10H6(mu-S)C10H6O-)P(O)-kappaP,kappaS}PdCl2](H2NC4H8X) (6a, X = O and 6b, X = NMe), via P-N bond cleavage. The crystal structures of compounds 1, 2a, 2b, 4a, and 6a are reported. Compound 6a is a rare example of crystallographically characterized anionic transition metal complex containing a thioether-phosphonate ligand. Most of these palladium complexes proved to be very active catalysts for the Suzuki-Miyaura reaction with excellent turnover number ((TON), up to 9.2 x 10(4) using complex 6a as a catalyst).     

Modeling the interface between islet amyloid polypeptide and insulin-based aggregation inhibitors: correlation to aggregation kinetics and membrane damage

Human islet amyloid polypeptide (hIAPP) forms cytotoxic fibrils in type-2 diabetes and insulin is known to inhibit formation of these aggregates. In this study, a series of insulin-based inhibitors were synthesized and assessed for their ability to slow aggregation and impact hIAPP-induced membrane damage. Computational studies were employed to examine the underlying mechanism of inhibition. Overall, all compounds were able to slow aggregation at sufficiently high concentrations (10× molar excess); however, only two peptides showed any inhibitory capability at the 1:1 molar ratio (EALYLV and VEALYLV). The results of density functional calculations suggest this is due to the strength of a salt bridge formed with the Arg11 side chain of hIAPP and the inhibitors' ability to span from the Arg11 to past the Phe15 residue of hIAPP, blocking one of the principal amyloidogenic regions of the molecule. Unexpectedly, slowing fibrillogenesis actually increased damage to lipid membranes, suggesting that the aggregation process itself, rather than the fibrilized peptide, may be the cause of cytotoxicity in vivo.     

Triclabendazole: An Intriguing Case of Co‐existence of Conformational and Tautomeric Polymorphism

The crystal polymorphism of the anthelmintic drug, triclabendazole ( TCB ), is described. Two anhydrates (Forms I and II), three solvates, and an amorphous form have been previously mentioned. This study reports the crystal structures of Forms I ( 1 ) and II ( 2 ). These structures illustrate the uncommon phenomenon of tautomeric polymorphism. TCB exists as two tautomers A and B. Form I (Z′=2) is composed of two molecules of tautomer A while Form II (Z′=1) contains a 1:1 mixture of A and B. The polymorphs are also characterized by using other solid‐state techniques (differential scanning calorimetry (DSC), thermal gravimetric analysis (TGA), PXRD, FT‐IR, and NMR spectroscopy). Form I is the higher melting form (m.p.: 177 °C, ΔH_f=≈105±4 J g^?1) and is the more stable form at room temperature. Form II is the lower melting polymorph (m.p.: 166 °C, ΔH_f=≈86±3 J g^?1) and shows high kinetic stability on storage in comparison to the amorphous form but it transforms readily into Form I in a solution‐mediated process. Crystal structure analysis of co‐crystals 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 further confirms the existence of tautomeric polymorphism in TCB . In 3 and 11 , tautomer A is present whereas in 4 , 5 , 6 , 7 , 8 , 9 , 10 the TCB molecule exists wholly as tautomer B. The DFT calculations suggest that the optimized tautomers A and B have nearly the same energies. Single point energy calculations reveal that tautomer A (in Form I) exists in two low‐energy conformations, whereas in Form II both tautomers A and B exist in an unfavorable high‐energy conformation, stabilized by a five‐point dimer synthon. The structural and thermodynamic features of 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 are discussed in detail. Triclabendazole is an intriguing case in which tautomeric and conformational variations co‐exist in the polymorphs.     

A one-pot catalysis: the strategic classification with some recent examples

In this "Emerging Area", the strategic classification of one-pot catalysis, i.e. cooperative, relay and sequential catalysis, is described. In order to illustrate this classification, we take the readers through a series of recent examples which utilize either metal-metal, metal-organo and organo-organo catalysts. The compilation clearly demonstrates the explosive growth and power of this field, which has become, in the last few years, an important technique particularly in the case of enantioselective catalysis.